Ho Maykin
SEC insider (Form 3/4/5 filer). CIK 0001646395. Director at AGIOS PHARMACEUTICALS, INC. (AGIO) and 3 other issuers. 24 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in SAN RAFAEL, CA.
Companies Ho Maykin has filed insider reports for
- AGIOS PHARMACEUTICALS, INC. (AGIO): Director
- KYNTRA BIO, INC. (KYNB): Director
- BIOMARIN PHARMACEUTICAL INC (BMRN): Director
- Neumora Therapeutics, Inc. (NMRA): Director
Ho Maykin
CIK: 0001646395
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (24 total)
- Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirect2.8K shares- - Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectRestricted stock units
2.9K shares- - Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectStock options (right to buy)
15K shares- - Jun 12, 2026KYNB
KYNTRA BIO, INC.
AwardDirectStock Option (Right to Buy)
7K shares- - Jun 2, 2026BMRN
BIOMARIN PHARMACEUTICAL INC
AwardDirect7.5K shares- - May 27, 2026NMRA
Neumora Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
80K shares- - Jun 20, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirect2.1K shares- - Jun 18, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectStock options (right to buy)
15.8K shares- - Jun 18, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectRestricted stock units
2.8K shares- - Jun 4, 2025FGEN
FIBROGEN INC
AwardDirectStock Option (Right to Buy)
120K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 |  AGIO AGIOS PHARMACEUTICALS, INC. | Exercise | 2,816 | - | $0 | Direct |
| Jun 18, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Award Restricted stock units | 2,927 | - | - | Direct |
| Jun 18, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Award Stock options (right to buy) | 14,950 | - | - | Direct |
| Jun 12, 2026 |  KYNB KYNTRA BIO, INC. | Award Stock Option (Right to Buy) | 7,000 | - | - | Direct |
| Jun 2, 2026 |  BMRN BIOMARIN PHARMACEUTICAL INC | Award | 7,490 | - | $0 | Direct |
| May 27, 2026 |  NMRA Neumora Therapeutics, Inc. | Award Stock Option (Right to Buy) | 80,000 | - | - | Direct |
| Jun 20, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise | 2,120 | - | - | Direct |
| Jun 18, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Award Stock options (right to buy) | 15,768 | - | - | Direct |
| Jun 18, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Award Restricted stock units | 2,816 | - | - | Direct |
| Jun 4, 2025 |  FGEN FIBROGEN INC | Award Stock Option (Right to Buy) | 120,000 | - | - | Direct |
1-10 of 24 transactions